# Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

> **NCT04790968** · NA · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 90 (actual)

## Conditions studied

- Prostatic Neoplasms
- Neoplasm Metastasis

## Interventions

- **DIAGNOSTIC_TEST:** PSMA-PET
- **DIAGNOSTIC_TEST:** PSMA-PET/MRI
- **DIAGNOSTIC_TEST:** PSMA-PET/CT

## Key facts

- **NCT ID:** NCT04790968
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-28
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-11-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790968, "Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04790968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*